e-learning
resources
Munich 2014
Tuesday, 09.09.2014
New and old players in fibrotic lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An animal model for granulomatosis with polyangiitis
L. Hinkofer, D. Jenne (München, Germany)
Source:
International Congress 2014 – New and old players in fibrotic lung disease
Session:
New and old players in fibrotic lung disease
Session type:
Thematic Poster Session
Number:
3918
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Hinkofer, D. Jenne (München, Germany). An animal model for granulomatosis with polyangiitis. Eur Respir J 2014; 44: Suppl. 58, 3918
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014
Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome
Source: International Congress 2014 – ILDs 1
Year: 2014
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Essential oils reduced lung inflammation in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum
Source: International Congress 2014 – ILDs 2
Year: 2014
An atypical presentation of granulomatosis with polyangiitis (GPA) with pituitary involvement
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Atypical variants of clinical course of sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Increased Severity of Asthma in Atopic Patients with Eosinophilic Granulomatosis with Polyangiitis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Pathogenic potential of an autoprocessed form of neutrophil elastase
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Inhibited IL-17A ameliorates sarcoid-like granulomatosis in mice
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Cognitive failure in sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 6
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept